Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On Therapies

The Asthma–COPD Overlap Syndrome

(2015) Dirkje S. Postma et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population

(2013) Roberto de Marco et al.   PLoS One

Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease

(2012) Erik Ingelsson et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Montelukast as an Add-On Therapy to Inhaled Corticosteroids in the Treatment of Severe Asthma in Elderly Patients

(2012) Andrzej Bozek et al.   JOURNAL OF ASTHMA

Doubly robust estimators of causal exposure effects with missing data in the outcome, exposure or a confounder

(2012) E.J. Williamson et al.   STATISTICS IN MEDICINE

Effect of age on asthma control: results from the National Asthma Survey

(2011) Neetu Talreja et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Long-acting Beta-Agonists with and without Inhaled Corticosteroids and Catastrophic Asthma Events

(2010) Shelley R. Salpeter et al.   AMERICAN JOURNAL OF MEDICINE

Impact of asthma controller medications on medical and economic resource utilization in adult asthma patients

(2010) Todd A. Lee et al.   CURRENT MEDICAL RESEARCH AND OPINION

An update on the safety of long-acting β-agonists in asthma patients using inhaled corticosteroids

(2010) Shelley R Salpeter   Expert Opinion On Drug Safety

Quarterly Assessment of Short-Acting β2-Adrenergic Agonist Use as a Predictor of Subsequent Health Care Use for Asthmatic Patients in the United States

(2010) Harris S. Silver et al.   JOURNAL OF ASTHMA

Direct costs of chronic obstructive pulmonary disease among managed care patients

(2010) Anand Dalal   International Journal of Chronic Obstructive Pulmonary Disease

Safety of long-acting  -agonists: urgent need to clear the air remains

(2009) R. Beasley et al.   EUROPEAN RESPIRATORY JOURNAL

Impact of Asthma Controller Medications on Clinical, Economic, and Patient-Reported Outcomes

(2009) Hiangkiat Tan et al.   MAYO CLINIC PROCEEDINGS

Balancing the Benefits and Risks of Inhaled Long-Acting Beta-Agonists — The Influence of Values

(2009) Judith M. Kramer   NEW ENGLAND JOURNAL OF MEDICINE

Risks of Long-Acting Beta-Agonists in Achieving Asthma Control

(2009) Jeffrey M. Drazen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Leukotriene Signaling in Atherosclerosis and Ischemia

(2008) Magnus Bäck   CARDIOVASCULAR DRUGS AND THERAPY

Asthma costs and utilization in a managed care organization

(2008) Robert S. Zeiger et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review

(2008) S Joos et al.   THORAX